Improving early detection of pancreatic cancer through better data coordination
Management and Data Coordination Unit for PCDC
This study is working to improve the early detection of pancreatic cancer by collecting and organizing samples from different people, which will help find better ways to identify the disease early and improve treatment options for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10901865 on NIH RePORTER |
What this research studies
This research focuses on enhancing the early detection of pancreatic ductal adenocarcinoma (PDAC), a highly lethal cancer, by creating a centralized resource for collecting and managing biospecimens. The project aims to gather well-annotated samples from diverse populations to aid in the discovery and validation of effective biomarkers for PDAC. By coordinating efforts across multiple institutions, the research will streamline data collection and analysis, ultimately improving the chances of early diagnosis and treatment for patients. The initiative will also involve strategic planning and logistical support to ensure efficient operation of the consortium.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for pancreatic cancer or those with early-stage symptoms.
Not a fit: Patients with advanced metastatic pancreatic cancer may not benefit from this research as it focuses on early detection.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection methods for pancreatic cancer, significantly enhancing patient survival rates.
How similar studies have performed: Previous research has shown promise in utilizing centralized biospecimen resources for cancer detection, indicating a strong potential for success in this approach.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Oberg, Ann Laura — Mayo Clinic Rochester
- Study coordinator: Oberg, Ann Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.